Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial.
Tanne
D
D
Department of Neurology, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Hashomer, Israel. tanne@post.tau.ac.il
Levine
S R
SR
Brey
R L
RL
Lin
H
H
Tilley
B C
BC
D000208:Acute Disease; D017153:Antibodies, Anticardiolipin / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D002545:Brain Ischemia / Q000097:blood* / Q000188:drug therapy; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D018450:Disease Progression; D004311:Double-Blind Method; D023261:Glasgow Outcome Scale / Q000706:statistics & numerical data; D006801:Humans; D007275:Injections, Intravenous; D009316:National Institutes of Health (U.S.) / Q000706:statistics & numerical data; D016017:Odds Ratio; D011237:Predictive Value of Tests; D020521:Stroke / Q000097:blood* / Q000188:drug therapy; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States
D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D010959:Tissue Plasminogen Activator